Turning Point Brands Inc (TPB) is expected to report $0.69 for 4Q. VYNE Therapeutics Inc (VYNE) is expected to report $-0.29 for 4Q. Werewolf Therapeutics Inc (HOWL) is expected to report $-0.43 for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback